1. Shiradkar M. R., Murahari K. K., Gangadasu H. R., Suresh T., Kalyan C. C., Panchal D., Kaur R., Burange P., Ghogare J., Mokale V., Raut M. Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents, Bioorg.Med. Chem. 2007, 15, P. 3997-4008.
2. Janin Y. Antituberculosis drugs: Ten years of research, Bioorg. Med. Chem.
2007, 15, P. 2479-2513.
3. Gursoy E., Guzeldemirci-Ulusoy N. Synthesis and primary cytotoxicity evaluation of new imidazo[2,1-b]thiazole derivatives, Eur. J. Med. Chem. 2007, 42, P.
320-326.
4. Kaymakcıoglu K. B., Oruc E. E., Unsalan S., Kandemirli F., Shvets N., Rollas S., Anatholy D. Synthesis and characterization of novel hydrazide-hydrazones and the study of their structure antituberculosis activity, Eur. J. Med. Chem. 2006, 41, P. 1253-1261.
5. Kalsi R., Shrimali M., Bhalla T. N., Barthwal J. P. Synthesis and anti inflammatory activity of indolyl
azetidinonesIndian, J. Pharm. Sci. 2006, 41,
P. 353-359.
6. Gemma S., Kukreja G., Fattorusso C., Persico M., Romano M., Altarelli M.,Savini L., Campiani G., Fattorusso E., Basilico N. Synthesis of N1-arylidene N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains, Bioorg. Med.
Chem. Lett. 2006, 16, P. 5384-5388.
7. Sriram D., Yogeeswari P., Madhu K. Synthesis and in vitro and in vivo antimycobacterial activity of isonicotinoyl hydrazones, Bioorg. Med. Chem. Lett. 2006,
15, P. 4502-4505.
8. Nayyar A., Jain R. Recent advances in new structural classes of anti tuberculosis agents, Curr. Med. Chem. 2006, 12, P. 1873¬1886.
9. Walcourt A., Loyevsky M., Lovejoy D. B., Gordeuk V. R., Richardson D. R. Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and -sensitive parasites, Int.J.Biochem. Cell Biol. 2004, 36,
P. 401-407.
Available Online At www.ijprbs.com
Research Article
Sonal Mehta, IJPRBS, 2013; Volume 2(1): 382-394
ISSN: 2277-8713
IJPRBS
10. Mamolo M. G., Falagiani V., Zampieri D., Vio L., Banfi E. , Scialino G. Synthesis and anti mycobacterial activity of (3,4-diaryl-3H-thiazole-2-ylidene)hydrazide derivatives, Farmaco 2003, 58, P. 631-637.
11. Terzioglu N., Gursoy A. Synthesis and anticancer evaluation of some new hydrazone derivatives of 2,6-dimethylimidazo[2,1-b]-[1,3,4]thiadiazole 5-carbohydrazide, Eur. J. Med. Chem. 2003,
38, P. 781-786.
12. Kucukguzel S. G., Oruc E. E., Rollas S., Sahin F., Ozbek A. Synthesis, Characterization and biological activity of novel 4-thiazolidinones, 1,3,4-oxadiazoles and some related compounds, Eur. J. Med.
Chem. 2002, 37, P. 197-206.
13. Rollas S., Gulerman N., Erdeniz H. Synthesis and antimicrobial activity of some new hydrazones of 4-fluorobenzoic acid hydrazide and 3-acetyl-2,5-disubstituted-1,3,4-oxadiazolines, Farmaco 2002, 57, P.
171-174.
14. Al- Mawsawi LQ, Dayam R., Taheri L., Witvrouw M., Debyser Z., Neamati N. Discovery of novel non-cytotoxic salicylhydrazide containing HIV-1 integrase inhibitors, Bioorg. Med. Chem. Lett. 2007,
17(23), P. 6472-6475.
15. Plasencia C., Daym R., Wang Q., Pinski J., Jr. Burke T. R., Quinn D. I., and Neamati N. Discovery and preclinical evaluation of a novel class of small-molecule compounds in hormone-dependent and -independent cancer cell lines, Mol. Cancer Ther. 2005,
4(7), P. 1105-1113.
16. Zhao H., Neamati N., Sunder S., Hong H., Wang S., Milne G. W., Pommier Y., Jr. Burke T. R. Hydrazide-containing inhibitors of HIV-1 integrase, .J. Med. Chem. 1997, 40(6), P. 937-941.
17. Bellina F. and Rossi R. Synthesis and biological activity of pyrrole, pyrroline and pyrrolidine derivatives with two aryl groups on adjacent positions, Tetrahedron 2006,
62, P. 7213-7256.
Thank you for copying data from http://www.arastirmax.com
